Subscribe
Share
Share
Embed
OCM kicks off its statutory license-cap review and a July 31 petition window while the 2026 Cannabis Omnibus Bill takes effect Aug. 1. Plus: Minnesota's $28M May sales record, Winona's first dispensary, Osseo's municipal shop, and the White Earth tribal compact.
Minnesota's cannabis market hit a July inflection point: OCM opened its statutory license-cap review, the 2026 Omnibus Bill takes effect Aug. 1, and May sales set a record. We break down what changes for operators, patients, and shoppers.
In this episode:
Sources:
Subscribe: mncannabishub.com
Will: —and that's the thing, Matilda, like, July hit and all of a sudden every cannabis reporter in the state is refreshing the OCM page like it's a Vikings score.
Matilda: Right? Because July 1 was the checkpoint, yeah?
Will: Yeah. Statutory trigger. OCM has to actually sit down and go, okay, are these license caps doing what we said they'd do.
Matilda: Which is what, exactly? Like in plain-person terms.
Will: Supply. Stability. Competition. And the big one — are we actually pushing the illicit market out.
Matilda: Okay so translation for someone who just wants to buy a gummy at Green Goods without a headache... this could mean more stores?
Will: Could. Or a different MIX of licenses. They can adjust the number AND the type.
Matilda: Hm.
Will: You don't sound convinced.
Matilda: I mean, regulators reviewing their own rules... historically a real thrill ride.
Will: Uff da, okay, fair.
Matilda: No but seriously — I'll believe adjustments when I see them on a shelf.
Will: That's the right instinct. Because the OTHER thing happening right now, and this is the one people are sleeping on...
Matilda: The petition window.
Will: The petition window. Yeah. Through 4 p.m. July 31.
Matilda: For?
Will: New cannabinoid products, new categories, new delivery methods. If you're an operator and you've got an idea that doesn't fit neatly into what's already legal, this is the door.
Matilda: Okay wait — 4 p.m. though? Not end of day?
Will: 4 p.m. Government hours, doncha know.
Matilda: Of course.
Will: So if you're a Stigma THC Beverages type of shop, or Simply Crafted, and you've been sitting on some format idea — clock is ticking.
Matilda: That's actually a big deal for beverage folks specifically, right? Because that space is moving so fast.
Will: Moving crazy fast. And I think Stigma's whole thesis has been, like, meet people where they already are, which is at the bar or at a cookout with a can in their hand.
Matilda: Instead of asking them to learn a whole new ritual.
Will: Exactly.
Matilda: Okay. Bigger picture though. The omnibus bill.
Will: Yeah. The big one.
Matilda: Walz signed it back in May. SF 4401, I think?
Will: SF 4401, HF 4203, signed May 26. Most of it kicks in August 1.
Matilda: Two weeks.
Will: Two weeks. Ope.
Matilda: Ope indeed.
Will: The headline thing — and this is genuinely a big structural change — is they're merging the medical supply chain and the adult-use supply chain into one operation.
Matilda: Wait, so a grower doesn't have to pick a lane anymore?
Will: Right. One unified supply chain. Which, I mean, if you talk to anyone on the cultivation side they've been asking for this for a while.
Matilda: Because running two parallel businesses is nuts.
Will: It's expensive and it's spendy and it slows everybody down.
Matilda: Okay push back on this though — doesn't the medical program lose something when you fold it in? Like, patients had a specific channel.
Will: That's the fair critique. And I'll be honest, I don't know how patient access is going to feel in September versus how it feels today.
Matilda: Yeah.
Will: I've seen the structural argument, the efficiency argument. I have NOT seen a clean answer on, like, is my aunt who's a medical patient going to walk into her regular spot and feel a difference.
Matilda: That's real. That's the thing to watch.
Will: Point people at mncannabishub.com — we'll be tracking that transition close.
Matilda: Okay so the other new thing in the bill — macrobusiness license?
Will: Yeah, this is the one that gets industry people leaning in.
Matilda: When does it start?
Will: January 1, 2027.
Matilda: So not immediately.
Will: Not immediately. But it replaces the old medical combination business type, and the scale is... different.
Matilda: How different?
Will: 38,000 square feet of canopy, scaling up to 45,000. Up to 8 retail locations.
Matilda: Whoa.
Will: Yeah.
Matilda: Okay that's a real operator. That's not a mom-and-pop.
Will: That's a real operator. And I think that's the tension — Minnesota's whole pitch was, we're going to do this differently than Colorado, differently than California, we're going to keep it more equity-forward, more distributed.
Matilda: And a macrobusiness license is... not that.
Will: It's a different signal, at least.
Matilda: Hm.
Will: BUT — and this is important — the SAME bill also raised the outside-investment cap for social equity operators.
Matilda: To what?
Will: 33%. Up from 10.
Matilda: Okay that's significant.
Will: Across up to 4 businesses. And the verified SE applicants have to keep at least 65% ownership and governance.
Matilda: So they can bring in real capital without losing control of the company.
Will: That's the pitch. Whether it works in practice — talk to me in a year.
Matilda: Fair.
Will: Because 10% was, like, symbolic. Nobody was writing a check for 10% of a cannabis startup.
Matilda: Right, no VC does that math.
Will: 33% at least gets you in the room.
Matilda: Okay. Numbers time. What's the market actually doing?
Will: May was a record.
Matilda: How much?
Will: 28 million combined. 18 adult-use, 10 medical.
Matilda: In one month.
Will: One month.
Matilda: Okay that's real money.
Will: That's real money and it's still supply-constrained.
Matilda: Right, the testing thing.
Will: The testing thing. Two fully operational state-licensed labs. That's the whole bottleneck.
Matilda: Two.
Will: Two.
Matilda: For an entire state's flower supply.
Will: For an entire state.
Matilda: Cool cool cool.
Will: Yeah.
Matilda: So when people go to Wildflower North Loop and something they wanted is out — that's why.
Will: Frequently, yeah. It's not that the plant doesn't exist. It's that it's sitting somewhere waiting for a lab slot.
Matilda: That's wild.
Will: And license-wise — as of mid-June, 240 issued, 1,332 preliminarily approved, 527 qualified, 387 denied.
Matilda: Okay hold on—
Will: Yeah.
Matilda: 1,332 preliminarily approved but only 240 actually issued?
Will: Yeah.
Matilda: That gap is HUGE.
Will: That gap is the whole story of Minnesota cannabis right now.
Matilda: So people are sitting on approvals but they can't actually open.
Will: Real estate, local approvals, capital, buildout — all of it. It's a pipeline problem, not a paperwork problem.
Matilda: Okay that reframes a lot for me. Because from the outside it looks like OCM is slow.
Will: OCM has its issues. But the issued number is not the whole picture.
Matilda: Got it.
Will: Speaking of opening — Winona.
Matilda: Winona got their first dispensary?
Will: First one. This month. 173 East Second Street.
Matilda: That's huge for Winona.
Will: That's huge for Winona. And I love that this is happening outside the Cities.
Matilda: Yeah because most of the coverage — including ours, honestly — skews Twin Cities heavy.
Will: Guilty.
Matilda: Very guilty.
Will: But this is the whole point of the state rollout. It's not just Edina Canna and Green Goods Bloomington. It's Winona. It's the river towns. It's up north.
Matilda: And then Osseo.
Will: Osseo's the OTHER interesting one.
Matilda: Municipal dispensary, right?
Will: Municipally-owned. Second one in the state.
Matilda: After Anoka.
Will: After Anoka Cannabis Company, which soft-opened in February. Osseo's targeting mid-2026.
Matilda: So the CITY runs the dispensary.
Will: The city runs it. Profits, theoretically, come back to the municipality.
Matilda: Okay I'm going to push back on this too.
Will: Go.
Matilda: Is this actually a good model? Or is it just a city trying to hoard the revenue?
Will: Uff da. That's the debate.
Matilda: Because on one hand — great, tax base, funds parks, funds whatever.
Will: Sure.
Matilda: On the other — a private operator can't compete with city hall. That's not a fair market.
Will: I think both those things are true. And I think it's going to depend a lot on how Osseo runs it.
Matilda: Meaning?
Will: Meaning if they run it like a professional retail operation with good buyers and good staff, cool. If they run it like a DMV with weed, it's going to be rough.
Matilda: A DMV with weed.
Will: You know what I mean!
Matilda: I know EXACTLY what you mean.
Will: Anoka's the tell. Watch Anoka. If Anoka's doing well six months in, the Osseo model has legs.
Matilda: That's fair.
Will: Okay, tribal side.
Matilda: Yeah, this is the part I think is genuinely, like, nationally interesting.
Will: Nationally interesting. Because White Earth Nation — Waabigwan Mashkiki — can now operate up to 8 off-reservation dispensaries statewide.
Matilda: Under the compact.
Will: Under the tribal-state compact. First of its kind in the country, basically.
Matilda: With limits though, right?
Will: One per city, three per county.
Matilda: Okay so they can't just stack five in Minneapolis.
Will: Right, it's spread out by design.
Matilda: And there are others operating.
Will: Lake Leaf out of Mille Lacs. Anang from Fond du Lac. NativeCare from Red Lake. Sweetest Grass, Leech Lake. Island Pezi, Prairie Island.
Matilda: That's a real footprint.
Will: That's a real footprint. And they got to market fast, because they weren't waiting on OCM licensing the way state-side operators were.
Matilda: Right. Sovereignty is a real regulatory shortcut.
Will: I wouldn't call it a shortcut exactly, but yeah, they had a different path.
Matilda: Fair, that's a better way to say it.
Will: Okay we should do the education segment.
Matilda: Yes. Terpene time.
Will: Terpene time.
Matilda: Which one today?
Will: Myrcene. Beta-myrcene.
Matilda: Okay so this is the one people associate with couch-lock, right?
Will: That's the reputation. Sedative, relaxing.
Matilda: Is that real or is that vibes?
Will: Somewhere in between, honestly.
Matilda: Okay say more.
Will: So NIH-hosted research — this is real published stuff — shows myrcene enhances GABA-A receptor activity.
Matilda: Which is...
Will: The inhibitory pathway. Same pathway benzodiazepines work on.
Matilda: Whoa. Same pathway as like a Xanax.
Will: Same PATHWAY. Not the same drug, not the same magnitude — but yeah, that's the mechanism people are pointing at when they say relaxing.
Matilda: Okay.
Will: There's also sedative-hypnotic effects via serotonergic signaling. In animal models.
Matilda: Ah. Animal models.
Will: Animal models. Which is the caveat I want to be really clear about.
Matilda: Because a mouse dose is not a human dose.
Will: A mouse dose is not a human dose, human dose-response is not nailed down, and you should not walk into Edina Canna asking for the highest-myrcene strain expecting to get horse-tranquilized.
Matilda: Noted.
Will: BUT — there's also a double-blind human pilot that looked at myrcene and simulated driving and divided attention.
Matilda: And?
Will: It affected those measures.
Matilda: Meaning don't drive.
Will: Meaning don't drive. Which, you shouldn't be driving anyway, but this is a specific data point that says myrcene itself, not just THC, may impact attention.
Matilda: That's actually useful. Because most of the driving conversation is THC-centric.
Will: Right. And myrcene is in a LOT of common strains. It's one of the most abundant terpenes on the market.
Matilda: So if you're a nighttime user, myrcene is maybe your friend.
Will: Maybe your friend. If you're going to a concert and want to stay sharp — maybe check the terpene profile.
Matilda: Menus at mncannabishub.com list terpenes for a lot of these products, right?
Will: Where operators publish them, yeah. Not every brand does. Push the ones that don't.
Matilda: Okay, quick community note before we wrap.
Will: CannaFest.
Matilda: CannaFest is back.
Will: November 12 at The Lowlands in St. Paul.
Matilda: Minnesota Monthly's festival.
Will: Yep.
Matilda: That's a good one. Last year was fun.
Will: Last year was fun. And I think this year, given everything we just talked about with the omnibus bill, the license expansion, tribal operators in the mix — it's going to feel like a different event.
Matilda: More mature.
Will: More mature is a good word.
Matilda: Okay concrete takeaway. If someone's listening and they're like, cool, what do I DO with all this — what do you tell them?
Will: One thing. If you buy cannabis in Minnesota, between now and August 1... pay attention to what's on the shelf at your regular spot.
Matilda: Because?
Will: Because the supply chain merger hits August 1, and prices, selection, brand availability — some of that is going to shift. Not overnight, not dramatically, but it'll shift.
Matilda: So take a mental snapshot now.
Will: Take a mental snapshot. Know your baseline. Then in September, October, you'll actually be able to tell if the change helped you or not.
Matilda: That's good. That's a real one.
Will: And if you're an operator — the petition window closes July 31 at 4 p.m. If you've got an idea, file it.
Matilda: Don't sit on it.
Will: Don't sit on it.
Matilda: Okay Will, good one.
Will: Good one, Matilda. Skol.
Matilda: Skol.
Will: For menus, dispensary reviews, and the latest on all of this — mncannabishub.com. We'll be tracking the August 1 rollout close.
Matilda: See you next week.
Will: See you next week.
Minnesota's weekly cannabis news, dispensary updates, and policy briefings. Recreational and medical, OCM moves, new strains, dispensary openings, and the people running the industry. Brought to you by mncannabishub.com and Leafwell (code MNHUB — $99 medical card visits).